Global Laboratory Proficiency Testing Market Size Study & Forecast, by Industry (Clinical Diagnostics, Microbiology, Pharmaceutical, Food & Animal Feed, Water, Opioid) and Technology (PCR, Cell Culture) and Regional Forecasts 2025-2035

The Global Laboratory Proficiency Testing Market is valued at approximately USD 1.27 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% over the forecast period 2025-2035. Laboratory proficiency testing (PT) is a critical mechanism that allows laboratories to evaluate and benchmark their analytical performance against standardized reference samples. These programs are indispensable across diverse sectors including clinical diagnostics, microbiology, pharmaceutical research, food safety, water testing, and opioid monitoring. By ensuring accuracy, reproducibility, and regulatory compliance, proficiency testing mitigates risks, enhances credibility, and supports evidence-based decision-making in laboratory operations. The market growth is underpinned by increasing regulatory stringency, rising awareness regarding laboratory quality assurance, and the surge in complex diagnostic testing requirements worldwide.

The accelerating adoption of advanced technologies such as PCR and cell culture for molecular diagnostics and microbial analysis has significantly amplified the demand for proficiency testing. Laboratories are increasingly compelled to participate in PT programs to meet international accreditation standards, maintain patient safety, and validate novel testing protocols. According to industry data, the demand for clinical laboratory testing has witnessed consistent growth in 2023 and 2024, driven by higher incidences of chronic and infectious diseases, the expansion of diagnostic networks, and technological sophistication in assay methodologies. Nonetheless, high operational costs and the complexity of implementing multi-technology PT programs may constrain market growth, particularly in resource-limited settings, over the forecast period 2025-2035.

The detailed segments and sub-segments included in the report are:

By Industry:
• Clinical Diagnostics
• Microbiology
• Pharmaceutical
• Food & Animal Feed
• Water
• Opioid

By Technology:
• PCR
• Cell Culture

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Clinical Diagnostics is Expected to Dominate the Market

Among the industry segments, clinical diagnostics is poised to dominate the laboratory proficiency testing market, accounting for the largest share. The segment’s supremacy is attributed to the rapid expansion of diagnostic laboratories, increasing disease burden, and the demand for precise and validated test results that inform clinical decision-making. Simultaneously, microbiology and pharmaceutical laboratories are witnessing accelerated adoption of PT programs due to the rising complexity of assays and stringent regulatory mandates. While clinical diagnostics leads in market share, emerging applications in food & animal feed, water, and opioid testing present notable growth opportunities fueled by public health initiatives and regulatory compliance requirements.

PCR Technology Leads in Revenue Contribution

When segmented by technology, PCR-based proficiency testing currently commands the highest revenue contribution. The widespread application of PCR in infectious disease detection, genetic testing, and molecular research ensures robust demand for validation and benchmarking. In contrast, cell culture-based PT programs, though smaller in share, are gaining traction due to the rise of advanced cell-based assays, vaccine research, and regenerative medicine. This bifurcation illustrates a nuanced market dynamic: PCR dominates revenue generation owing to high-volume usage, while cell culture technologies represent the fastest-growing niche segment due to innovation-driven demand.

North America retains a commanding presence in the global laboratory proficiency testing market, driven by well-established diagnostic infrastructure, regulatory enforcement, and high participation in accreditation programs. Europe follows closely, benefiting from sophisticated laboratory networks, research initiatives, and stringent quality standards. Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth during the forecast period, fueled by expanding healthcare systems, increased public and private investment in laboratory facilities, and rising awareness of quality assurance practices across countries like China and India. Latin America and the Middle East & Africa are gradually integrating proficiency testing programs, supported by government initiatives and rising adoption of international accreditation standards.

Major market players included in this report are:
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Abbott Laboratories
• Merck KGaA
• Siemens Healthineers AG
• Randox Laboratories Ltd
• LGC Limited
• Charles River Laboratories International, Inc.
• Nova Biomedical
• Becton, Dickinson and Company
• IDEXX Laboratories, Inc.
• LabCorp
• Roche Diagnostics
• Ortho Clinical Diagnostics

Global Laboratory Proficiency Testing Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more